Scientists are studying the few extraordinary individuals whose bodies seem able to naturally defend themselves from HIV in ...

For decades, HIV treatment has depended on one hard truth: once medication stops, the virus usually comes roaring back.

Biomedical researchers and policy experts decried the change when it was proposed this spring. STAT’s Anil Oza has the latest ...

Peer reviewed publication details pivotal data, demonstrating 30% improvement in disease-free survival (DFS) in patients with ...

Persistent viral infections pose a unique challenge to the immune system. Prolonged antigen exposure drives T cells into a state of exhaustion — a ...

Company plans to submit a Biologics License Application (BLA) for aglatimagene besadenovec (aglatimagene or CAN-2409) in localized, intermediate- ...

Extended follow-up data from the phase 3 study (20 months after reported topline data, median follow-up 58 months) confirmed a statistically significant and clinically meaningful improvement in ...

Detailed price information for GT Biopharma Inc (GTBP-Q) from The Globe and Mail including charting and trades.

Here’s what to know about the symptoms and spread of the virus, which has sickened people in the Democratic Republic of Congo and Uganda. By Dani Blum Global health officials are raising alarms about ...

Global health officials are tracking an outbreak of Ebola caused by a rare species of orthoebolavirus called the Bundibugyo virus that has so far killed more than 130 people and infected more than 500 ...

For many people, news of a virus outbreak on a cruise ship immediately brings back memories of COVID spreading when the Ruby Princess docked in Sydney in March 2020. Of the passengers and crew who ...